Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 96.00 | |
2 mg | In stock | $ 138.00 | |
5 mg | In stock | $ 233.00 | |
10 mg | In stock | $ 326.00 | |
25 mg | In stock | $ 478.00 | |
50 mg | In stock | $ 688.00 | |
100 mg | In stock | $ 987.00 | |
500 mg | In stock | $ 1,980.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 259.00 |
Description | Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2. |
Targets&IC50 | JAK2:0.72 nM, JAK1:33 nM, TYK2:22 nM, JAK3:39 nM |
In vitro | Ilginatinib maleate(NS-018 maleate) is highly active against JAK2 with a 50% inhibition (IC(50)) of <1 n, and had 30-50-fold greater selectivity for JAK2 over other JAK-family kinases, such as JAK1, JAK3 and tyrosine kinase 2.?In addition to JAK2, NS-018 inhibited Src-family kinases.?NS-018 showed potent antiproliferative activity against cell lines expressing a constitutively activated JAK2 (the JAK2V617F or MPLW515L mutations or the TEL-JAK2 fusion gene;?IC(50)=11-120 n), but showed only minimal cytotoxicity against most other hematopoietic cell lines without a constitutively activated JAK2[1]. |
In vivo | Ilginatinib maleate(NS-018 maleate) preferentially suppressed in vitro erythropoietin-independent endogenous colony formation from polycythemia vera patients.?NS-018 also markedly reduced splenomegaly and prolonged the survival of mice inoculated with Ba/F3 cells harboring JAK2V617F.?In addition, NS-018 significantly reduced leukocytosis, hepatosplenomegaly and extramedullary hematopoiesis, improved nutritional status, and prolonged survival in JAK2V617F transgenic mice.?suggest that NS-018 will be a promising candidate for the treatment of MPNs[1]. |
Synonyms | NS-018 maleate |
Molecular Weight | 505.5 |
Formula | C25H24FN7O4 |
CAS No. | 1354799-87-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (59.35 mM)
H2O: < 0.1 mg/mL (insoluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ilginatinib maleate 1354799-87-3 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK Inhibitor JAK3 NS 018 inhibit JAK2 NS018 Maleate Ilginatinib NS-018 Maleate bioavailable NS018 orally NS-018 JAK1 Janus kinase NS-018 maleate Tyk2 NS 018 Maleate Ilginatinib Maleate inhibitor